Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 8Gastrointestinal 3Dermatologic 3Other 2Lymphoid 2Genitourinary 2Thoracic 1Other neoplasm 1Other hematologic neoplasm 1

Conditions

Colorectal Neoplasms 2Wound Infection 1Surgical Wound Infection 1Sarcopenia 1Postoperative Complications 1Phagocyte Bactericidal Dysfunction 1Obesity 1Malnutrition 1Barrett Esophagus 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Docosahexaenoic Acids × Gastrointestinal × Clear all
NCT03598413 2022-09-28

PROTEIN

Royal Surrey County Hospital NHS Foundation Trust

Phase NA Completed
40 enrolled
Gastrointestinal

Phagocyte Bactericidal Dysfunction, Postoperative Complications, Surgical Wound Infection, Wound Infection, Colorectal Neoplasms, Malnutrition, Sarcopenia

NCT01733147 2022-01-11

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Mayo Clinic

Phase 4 Completed
60 enrolled 6 charts
GastrointestinalOther

Barrett Esophagus, Obesity

NCT01070355 2011-10-21

EMT

University of Leeds

Phase 2 Completed
88 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡